SEELOS THERAPEUTICS INC's ticker is SEEL and the CUSIP is 81577F109. A total of 109 filers reported holding SEELOS THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.98 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,995 | -36.7% | 43,451 | +137.7% | 0.00% | – |
| Q1 2023 | $12,637 | -25.7% | 18,283 | -26.7% | 0.00% | – |
| Q2 2022 | $17,000 | -39.3% | 24,951 | -25.4% | 0.00% | – |
| Q1 2022 | $28,000 | -81.0% | 33,460 | -63.1% | 0.00% | – |
| Q4 2021 | $147,000 | -68.7% | 90,775 | -53.3% | 0.00% | – |
| Q3 2021 | $469,000 | -18.9% | 194,300 | -11.2% | 0.00% | – |
| Q2 2021 | $578,000 | -76.6% | 218,884 | -55.7% | 0.00% | -100.0% |
| Q1 2021 | $2,466,000 | +10621.7% | 494,135 | +3240.6% | 0.00% | – |
| Q4 2020 | $23,000 | +91.7% | 14,792 | +25.6% | 0.00% | – |
| Q2 2020 | $12,000 | -92.9% | 11,777 | -76.5% | 0.00% | – |
| Q1 2019 | $168,000 | – | 50,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 508,000 | $249,000 | 0.10% |
| 1492 Capital Management LLC | 150,000 | $74,000 | 0.09% |
| Uniplan Investment Counsel, Inc. | 2,069,121 | $1,014,000 | 0.08% |
| ARDSLEY ADVISORY PARTNERS LP | 70,000 | $34,000 | 0.01% |
| Spark Investment Management LLC | 35,210 | $17,000 | 0.01% |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | 191,000 | $94,000 | 0.00% |
| WealthPLAN Partners, LLC | 20,000 | $15,000 | 0.00% |
| Procyon Advisors, LLC | 2,500 | $1,000 | 0.00% |
| Renaissance Technologies | 1,078,379 | $529,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |